Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.94B P/E - EPS this Y - Ern Qtrly Grth -
Income -55.9M Forward P/E -15.37 EPS next Y -34.80% 50D Avg Chg 4.00%
Sales 43k PEG - EPS past 5Y - 200D Avg Chg 54.00%
Dividend N/A Price/Book 8.51 EPS next 5Y - 52W High Chg -12.00%
Recommedations 3.00 Quick Ratio 11.54 Shares Outstanding 105M 52W Low Chg 218.00%
Insider Own 103.63% ROA -12.74% Shares Float 93.36M Beta 1.90
Inst Own 75.47% ROE -21.67% Shares Shorted/Prior 2.22M/2.39M Price 18.44
Gross Margin 100.00% Profit Margin - Avg. Volume 2,076,055 Target Price 23.41
Oper. Margin -133,658.14% Earnings Date Nov 12 Volume 26,174,709 Change 0.00%
About Trillium Therapeutics Inc.

As of November 17, 2021, Trillium Therapeutics Inc. was acquired by Pfizer Inc. Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.

TRIL Chatroom

User Image BloodyPortfolio Posted - 08/19/24

$VKTX No Fade for the shorts! It's happening here - $TRIL $IMGN.

User Image RizKayBiznuts Posted - 2 months ago

$TRIL $cdt similarities abound

User Image RKLB_Bull Posted - 2 months ago

$CDT back in 2020 Pfizer $PFE showed interest in $TRIL and acquired it in 2021 for 2B. And now $AZN is interested in $CDT and who knows will acquire in an year or so. So this cannot be unnoticed they must have researched on CDTs potential before giving them the recent deal. Think about it folks just don't fomo into news and sell short. In this market patience is needed and it pays in the end. My DD on this company looks solid so far and I'm long here with 233K shares. Will add huge on any dips if at all. My target price is 5$ not expecting in days or a months I can wait years for it. No urgency. I know how biotechs work and risks involved in it. My recent plays are ATOS and APLT I believed in them and banked

User Image sharlena_cia_gov Posted - 07/28/24

$TRIL drop these people they a ponzi scheme

User Image BloodyPortfolio Posted - 3 months ago

$VKTX I want $TRIL or $IMGN kind of movement. LFG!

User Image soll Posted - 3 months ago

@NEWBIGTECH always watching, sitting on 100k shares. Watched $TRIL for 2+ years and owned 88k shares when their buyout was announced.

User Image kamikaze_andy Posted - 05/30/24

$APDN Has the $TRIL at 0.30 feel to it right now. Resistance at 12$ - upcoming catalysts.

User Image boilerrm04 Posted - 05/30/24

@Apr4609 @SuperCool5000 yup i would just like to add though, just bc og significant BP ownership doesnt guarantee success. $PFE invested in $Tril yes but 3 other duds at the same time like $FIXX which now became $Q32 so there are no guarantees but the investment a nice footnote.

User Image beforethedeluge Posted - 5 months ago

Dough's tweet on X: BAIRD - nice nugget tonight on $LPTX As part of a $40M private placement in April, Gilead $GILD, Skorney) bought ~$15M in shares. A representative from Gilead is joining Leap's Scientific Advisory Board, which could help to cultivate a deeper scientific relationship. $TRIL 2.0šŸ‘

User Image DeepDown Posted - 5 months ago

$ALLR this is another $TRIL in the making. watch out

User Image DeepDown Posted - 5 months ago

$ALLR this is how $tril looks like back then.

User Image DeepDown Posted - 5 months ago

$ALLR this is similar to $TRIL a few years ago. $pfe bought it for 2.3B

User Image DeepDown Posted - 5 months ago

$ALLR remember one junky stock called $TRIL . It was trading at 0.25 at some time, but has decent cd47 assets. $PFE eventually bought it up for 2.3B, or 18.5 per share, cash. was in it

User Image boilerrm04 Posted - 5 months ago

@GSMITH10107 i am still a bit weary just short term. $PFE bought $TRIL at $12.84 and rode it down to $4.89 so just bc big investment doesnt mean automatic home run but took a yearand a half and $PFE took them out at $18.44

User Image AMbiotech Posted - 04/25/24

@VernCapital Iā€™ve been following XA for years. The stock is at an all time low with an approved device. They had over two years to market and sell and rollout has been beyond slow. You can rave about insider buys all the time but no one cares anymore. CEO Lisi doesnā€™t know how to do a confernev callā€¦he is asleep at the wheel and thatā€™s not good for any company let alone a small cap bio. Was in $TRIL from and its day and night what a good CEO who cares about its shareholders can do for a company

User Image The_Dream_Team Posted - 04/23/24

$TRIL,,,,,,,,,,,,, https://www.forbes.com/sites/jakezamansky/2013/08/08/the-great-vampire-squid-keeps-on-sucking/?sh=47c5415e7df8

User Image ianchris Posted - 04/23/24

@samuelm7 @boilerrm04 I was in $TRIL too but was super happy with $17.50 as I owed 8k shares at a $3 avg in the end. The days in 2019 at $0.25 were terrifying thoā€¦

User Image boilerrm04 Posted - 04/19/24

$lptx i do remember one thing from The $tril days. They announced 6 new studies June 2020 when we were all hoping for buyout. Stock sank from $20 to $4.89. $pfe bought them out 2 months later in august for $18.44 so anything is possible.

User Image STOP_Whining Posted - 6 months ago

@FE123 $TRIL had the same pattern just before getting bought out. Patience will pay off for investors in $IOVA

User Image SpringGunner Posted - 6 months ago

$GOEV This reminds me of $TRIL from a couple of years ago. Just when they started getting results with their molecules article after article came out about their cash burn rate and them not making money. The message boards would fill up and go ballistic with negative comments every time they would give an investor update with good news and progress. YouTube had video after video saying there was no catalyst to make it move up and to get out. They ran it down to a little over $4 before Pfizer bought it out for $18.50. I got fat on that one. 10,000 shares at $5.23 Last year I remember an article on Canoo saying to sell and get out because the market for three wheeled vehicles was already saturated. Honestly, how low is the bar for these guys to get a writing job.

User Image BrandNewLambo Posted - 03/26/24

$TRIL Been looking for the next Jan Svarka. Thinking David Lazar may be worth keeping an eye on at $OPGN

User Image Koepkesd Posted - 03/22/24

@iBoughtTheWrongTicker THe $TRIL ticker doesnā€™t exist anymore. What happened with it? Epic rally?

User Image Gunnar1 Posted - 03/21/24

@Steve_TheBull_Rogers Okay, here's some anecdotal evidence: I remember that around 2019/2020 it was also the case with $TRIL that IR never answered (ask @rockytrades). Then came the BO by Pfizer. Meanwhile at $TCON, the CEO himself responded a few times when Rocky mailed him. But all in all, it was a absolute shitshow. So the lesson is: never trust a company that reply to your emails. šŸ˜‰

User Image iBoughtTheWrongTicker Posted - 03/19/24

$ATOS if newbies come and click in the 3/6/12 mo chart and think ahhhh itā€™s already reached its potential itā€™s up 125% in a year - uhhh dudes this shit was up on less news in the $9ā€™s, the market cap is still a measly $160M. When I had $TRIL at a dollar, and it ran to $7 people thought the same, and after P2 readout data, Pfizer scooped them up for $18.50. This is biopharm and itā€™s the riskiest segment but also the one with the most payoff. Multiples are expected, not your S&P average type gains. We are literally just getting started. And catalysts are RIGHT AROUND THE CORNER.

User Image Metal_Health Posted - 03/15/24

@outNabout $BREA that 57 million volume gap will be filled and much more. This stock reminds me of $TRIL I started buying the hell out of that when it dropped from $4 to $1.75. $PFE acquired them in 2017 for $18.50/share.

User Image iBoughtTheWrongTicker Posted - 03/15/24

@Lemonz32 @dcajic2 Iā€™ve posted this before but $TRIL was picked up on positive data at P2ā€¦Pfizer didnā€™t seem to think twice about it. I held on all the way through the buyout at $18.50. My first share was picked up under $2ā€¦

User Image iBoughtTheWrongTicker Posted - 7 months ago

@chrundrel lesson learned if you like what youā€™re seeing and you donā€™t need the money immediately and you monitor it daily why even have a SLā€¦bios fluctuate to a much wider degree as other stocks but with great risk does occasionally come great reward. Held $TRIL straight through P2 data and buyout at $18.5 another oncology drug

User Image F14TomcatGuy Posted - 7 months ago

$GNS some of the companies I invested in had massive drops before they mooned. $TRIL $PR (CDEV). The market will drop good stocks on purpose to make you sell so the "ones in the know" can buy more shares lower. They will drag it out for a while to get most investors to sell. Then boom news hits and it rockets. Now you and others will chase the stock driving up the price and then they will sell with a massive profit.

User Image Longroader Posted - 02/16/24

$SGMO Fabry sale, Hem A update, partnership.....not selling at $1 if its going to $10. $TRIL 77x returns

User Image ianchris Posted - 8 months ago

@OldFngGuy hahaha I do some pennies on the side for fun when 90% of my accounts are in the broad market. I made $500k on $TRIL if you read back that far on my account. It came down to $0.25 at the min and then sold to Pfizer for $17.50/share. Owned 100k shares at one point.

Analyst Ratings
Craig-Hallum Hold Aug 24, 21
JMP Securities Market Perform Aug 24, 21
HC Wainwright & Co. Neutral Aug 23, 21
Benchmark Buy Apr 14, 21
HC Wainwright & Co. Buy Nov 18, 20
Evercore ISI Group Outperform Oct 12, 20
HC Wainwright & Co. Buy Sep 10, 20
JMP Securities Market Outperform Sep 9, 20
Craig-Hallum Buy Aug 17, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Uger Robert Chief Scientific Off.. Chief Scientific Officer Apr 09 Option 0.3 3,646 1,094 3,646 04/09/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Apr 09 Sell 10.82 3,646 39,450 04/09/21
Petrova Penka Chief Development Of.. Chief Development Officer Apr 09 Option 1.83 5,312 9,721 5,312 04/09/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Mar 10 Option 0.3 3,646 1,094 3,646 03/10/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Mar 10 Sell 10.11 3,646 36,861 03/10/21
Petrova Penka Chief Development Of.. Chief Development Officer Feb 10 Option 4.41 5,820 25,666 508 02/10/21
Petrova Penka Chief Development Of.. Chief Development Officer Feb 10 Sell 13.41 5,820 78,046 02/10/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Feb 10 Option 4.41 7,147 31,518 584 02/10/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Feb 10 Sell 13.39 7,147 95,698 02/10/21
Skvarka Jan President and CEO President and CEO Jan 15 Option 0.43 25,000 10,750 19,581 01/15/21
Skvarka Jan President and CEO President and CEO Jan 15 Sell 15.03 25,000 375,750 01/15/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 13 Option 9.57 584 5,589 584 01/13/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 13 Sell 15.2 584 8,877 01/13/21
Parsons James T. Chief Financial Offi.. Chief Financial Officer Jan 12 Option 7.24 8,505 61,576 8,505 01/12/21
Parsons James T. Chief Financial Offi.. Chief Financial Officer Jan 12 Sell 15.79 8,505 134,294 01/12/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 12 Option 7.17 8,517 61,067 2,917 01/12/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 12 Sell 15.66 8,517 133,376 01/12/21
Petrova Penka Chief Development Of.. Chief Development Officer Jan 12 Option 3.33 2,604 8,671 2,604 01/12/21
Petrova Penka Chief Development Of.. Chief Development Officer Jan 12 Sell 15.5 2,604 40,362 01/12/21
Petrova Penka Chief Development Of.. Chief Development Officer Jan 11 Option 0.3 2,708 812 2,708 01/11/21
Petrova Penka Chief Development Of.. Chief Development Officer Jan 11 Sell 14.71 2,708 39,835 01/11/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 11 Option 0.3 3,646 1,094 3,646 01/11/21
Uger Robert Chief Scientific Off.. Chief Scientific Officer Jan 11 Sell 14.75 3,646 53,778 01/11/21